| Cat.No. | Name | Information |
|---|---|---|
| M1781 | Adezmapimod (SB203580) | Adezmapimod (SB203580) is a P38 MAPK inhibitor with an IC50 of 0.3-0.5 μM, which is 10 times less selective than SAPK3(106T) and SAPK4(106T), and inhibits PKB phosphorylation with an IC50 of 3-5 μM. |
| M2062 | SB 202190 | SB 202190 is a highly selective, potent and cell permeable inhibitor of p38 MAP kinase with IC50 values of 50 and 100 nM inhibiting p38α and p38β, respectively. |
| M1675 | BIRB796 | BIRB 796 (Doramapimod) is a protein kinase inhibitor of p38 MAPK with Kd of 100pM. |
| M1556 | Hesperetin | Hesperetin is a potent and broad-spectrum inhibitor against human UGT activity. |
| M28792 | SD-169 | SD-169 is an orally active ATP-competitive inhibitor of p38α MAPK, with an IC50 of 3.2 nM. SD-169 also weakly inhibits p38β MAPK with an IC50 of 122 nM. SD-169 prevents the development and progression of diabetes by inhibiting T cell infiltration and activation. |
| M28785 | MW-150 dihydrochloride dihydrate | MW-150 dihydrochloride dihydrate (MW01-18-150SRM dihydrochloride dihydrate) is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. MW-150 dihydrochloride dihydrate (MW01-18-150SRM dihydrochloride dihydrate) inhibits the ability of the endogenous p38α MAPK to phosphorylate an endogenous substrate MK2 in activated glia. |
| M28723 | MW-150 | MW150 (MW01-18-150SRM) is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. MW-150 inhibits the ability of the endogenous p38α MAPK to phosphorylate an endogenous substrate MK2 in activated glia. |
| M28515 | PF-05381941 | PF-05381941 is a potent dual inhibitor of TAK1/p38α, with IC50s of 156 and186 nM, respectively. |
| M28043 | ITX5061 | ITX5061 is a type II inhibitor of p38 MAPK and also an antagonist of scavenger receptor B1 (SR-B1). |
| M20380 | WAY-306955 | WAY-306955 is a modulator of transcriptional repression. |
| M20327 | GI-505946 | GI-505946 is a inhibitor of p38. |
| M20302 | WAY-299819 | WAY-299819 altering the lifespan of a eukaryotic organism |
| M20293 | WAY-628644 | WAY-628644 is a p38α inhibitor. |
| M20276 | WAY-656283 | WAY-656283 is a p38 kinase inhibitor. |
| M20233 | WAY-632613 | WAY-632613 is a p38 MAP Kinase inhibitor. |
| M20228 | WAY-630998 | WAY-630998 is a inhibitor of p38a kinase. |
| M20191 | WAY-603359 | WAY-603359 altering the lifespan of a eukaryotic organism |
| M20082 | WAY-313013 | WAY-313013 is a p38a Mitogen-Activated Protein Kinase inhibitor |
| M20042 | WAY-270968 | WAY-270968 is a p38 MAP Kinase inhibitor. |
| M20041 | WAY-270966 | WAY-270966 is a p38 MAP Kinase inhibitor. |
| M18154 | Kaempferol 3-glucorhamnoside | Kaempferol 3-glucorhamnoside |
| M18049 | Methyl 4-hydroxy-3-methoxycinnamate | Methyl 4-hydroxy-3-methoxycinnamate |
| M14174 | BMS-582949 hydrochloride | BMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC50 of 13 nM. BMS-582949 hydrochloride displays a significantly improved pharmacokinetic profile and is effective in inflammatory disease. |
| M14162 | Cot inhibitor-1 | Cot inhibitor-1 (compound 28) is a selective tumor progression loci-2 (Tpl2) kinase inhibitor with an IC50 of 28 nM. Cot inhibitor-1 shows an inhibition of TNF-alpha production in human whole blood with an IC50 of 5.7 nM. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
